Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2016

01.02.2016 | Gynecologic Oncology

Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia

verfasst von: Matthias Jentschke, Victoria Hoffmeister, Philipp Soergel, Peter Hillemanns

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To characterize the clinical presentation and outcome of patients with vaginal intraepithelial neoplasia (VAIN).

Methods

Medical records of 65 women with VAIN treated between 2005 and 2012 at the colposcopy clinic of a German university hospital were retrospectively evaluated for VAIN grade, HPV status, VAIN localization, treatment method and relapse rate. Follow-up data were available for 53 patients (82 %).

Results

Mean age was 61 years (range 32–89 years). Most lesions (55 %) were found in the upper vaginal third; 42 % were multifocal. Multifocal VAIN was more frequently HPV positive than single lesions (p = 0.059). Of all women with known HPV status, 83 % were high-risk (HR) HPV positive and 32 % had a simultaneous CIN earlier or at the same time as the VAIN, mostly CIN 3 (66 %). Two-thirds had a hysterectomy in the past, often because of high-grade CIN. Most cases of VAIN were treated with CO2 laser vaporization. A relapse of the disease could be confirmed for 57 %. HR-HPV positive VAIN was significantly more likely to relapse than HR-HPV negative VAIN (p = 0.005). There were three cases of vaginal cancer with surrounding VAIN 3 or vaginal cancer diagnosed after primary treatment of VAIN 3 and one case of vaginal cancer during follow-up 22 months after the first laser vaporization. All of these cases were HR-HPV positive.

Conclusions

VAIN has a high relapse rate and a high progression rate to invasive cancer especially if HR-HPV positive. Therefore, adequate follow-up examinations are mandatory.
Literatur
1.
Zurück zum Zitat Dodge JA, Eltabbakh GH, Mount SL et al (2001) Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecol Oncol 83:363–369CrossRefPubMed Dodge JA, Eltabbakh GH, Mount SL et al (2001) Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecol Oncol 83:363–369CrossRefPubMed
2.
Zurück zum Zitat Murta EF, Neves Junior MA, Sempionato LR et al (2005) Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases. Arch Gynecol Obstet 272:261–264CrossRefPubMed Murta EF, Neves Junior MA, Sempionato LR et al (2005) Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases. Arch Gynecol Obstet 272:261–264CrossRefPubMed
3.
Zurück zum Zitat Yalcin OT, Rutherford TJ, Chambers SK et al (2003) Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure. Eur J Obstet Gynecol Reprod Biol 106:64–68CrossRefPubMed Yalcin OT, Rutherford TJ, Chambers SK et al (2003) Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure. Eur J Obstet Gynecol Reprod Biol 106:64–68CrossRefPubMed
5.
Zurück zum Zitat Liao JB, Jean S, Wilkinson-Ryan I et al (2011) Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity. Gynecol Oncol 120:108–112CrossRefPubMed Liao JB, Jean S, Wilkinson-Ryan I et al (2011) Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity. Gynecol Oncol 120:108–112CrossRefPubMed
6.
Zurück zum Zitat Hillemanns P, Wang X (2006) Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia. Gynecol Oncol 100:276–282CrossRefPubMed Hillemanns P, Wang X (2006) Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia. Gynecol Oncol 100:276–282CrossRefPubMed
7.
Zurück zum Zitat Frega A, French D, Piazze J et al (2007) Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection. Cancer Lett 249:235–241CrossRefPubMed Frega A, French D, Piazze J et al (2007) Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection. Cancer Lett 249:235–241CrossRefPubMed
8.
Zurück zum Zitat Gunderson CC, Nugent EK, Elfrink SH et al (2013) A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol 208(410):e411–e416 Gunderson CC, Nugent EK, Elfrink SH et al (2013) A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol 208(410):e411–e416
9.
Zurück zum Zitat Fehr MK, Baumann M, Mueller M et al (2013) Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. J Gynecol Oncol 24:236–241CrossRefPubMedPubMedCentral Fehr MK, Baumann M, Mueller M et al (2013) Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. J Gynecol Oncol 24:236–241CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Ratnavelu N, Patel A, Fisher AD et al (2013) High-grade vaginal intraepithelial neoplasia: can we be selective about who we treat? BJOG 120:887–893CrossRefPubMed Ratnavelu N, Patel A, Fisher AD et al (2013) High-grade vaginal intraepithelial neoplasia: can we be selective about who we treat? BJOG 120:887–893CrossRefPubMed
11.
Zurück zum Zitat Alemany L, Saunier M, Tinoco L et al (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50:2846–2854CrossRefPubMed Alemany L, Saunier M, Tinoco L et al (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50:2846–2854CrossRefPubMed
12.
Zurück zum Zitat Li H, Guo YL, Zhang JX et al (2012) Risk factors for the development of vaginal intraepithelial neoplasia. Chin Med J (Engl) 125:1219–1223 Li H, Guo YL, Zhang JX et al (2012) Risk factors for the development of vaginal intraepithelial neoplasia. Chin Med J (Engl) 125:1219–1223
13.
Zurück zum Zitat Li Z, Barron S, Hong W et al (2013) Surveillance for recurrent cancers and vaginal epithelial lesions in patients with invasive cervical cancer after hysterectomy: are vaginal cytology and high-risk human papillomavirus testing useful? Am J Clin Pathol 140:708–714CrossRefPubMed Li Z, Barron S, Hong W et al (2013) Surveillance for recurrent cancers and vaginal epithelial lesions in patients with invasive cervical cancer after hysterectomy: are vaginal cytology and high-risk human papillomavirus testing useful? Am J Clin Pathol 140:708–714CrossRefPubMed
14.
Zurück zum Zitat Schockaert S, Poppe W, Arbyn M et al (2008) Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study. Am J Obstet Gynecol 199(113):e111–e115 Schockaert S, Poppe W, Arbyn M et al (2008) Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study. Am J Obstet Gynecol 199(113):e111–e115
15.
Zurück zum Zitat Kim HS, Park NH, Park IA et al (2009) Risk factors for recurrence of vaginal intraepithelial neoplasia in the vaginal vault after laser vaporization. Lasers Surg Med 41:196–202CrossRefPubMed Kim HS, Park NH, Park IA et al (2009) Risk factors for recurrence of vaginal intraepithelial neoplasia in the vaginal vault after laser vaporization. Lasers Surg Med 41:196–202CrossRefPubMed
16.
Zurück zum Zitat Luyten A, Hastor H, Vasileva T et al (2014) Laser-skinning colpectomy for extended vaginal intraepithelial neoplasia and microinvasive cancer. Gynecol Oncol 135:217–222CrossRefPubMed Luyten A, Hastor H, Vasileva T et al (2014) Laser-skinning colpectomy for extended vaginal intraepithelial neoplasia and microinvasive cancer. Gynecol Oncol 135:217–222CrossRefPubMed
17.
Zurück zum Zitat Zeligs KP, Byrd K, Tarney CM et al (2013) A clinicopathologic study of vaginal intraepithelial neoplasia. Obstet Gynecol 122:1223–1230CrossRefPubMed Zeligs KP, Byrd K, Tarney CM et al (2013) A clinicopathologic study of vaginal intraepithelial neoplasia. Obstet Gynecol 122:1223–1230CrossRefPubMed
18.
Zurück zum Zitat Wee WW, Chia YN, Yam PK (2012) Diagnosis and treatment of vaginal intraepithelial neoplasia. Int J Gynaecol Obstet 117:15–17CrossRefPubMed Wee WW, Chia YN, Yam PK (2012) Diagnosis and treatment of vaginal intraepithelial neoplasia. Int J Gynaecol Obstet 117:15–17CrossRefPubMed
19.
Zurück zum Zitat Wang Y, Kong WM, Wu YM et al (2014) Therapeutic effect of laser vaporization for vaginal intraepithelial neoplasia following hysterectomy due to premalignant and malignant lesions. J Obstet Gynaecol Res 40:1740–1747CrossRefPubMed Wang Y, Kong WM, Wu YM et al (2014) Therapeutic effect of laser vaporization for vaginal intraepithelial neoplasia following hysterectomy due to premalignant and malignant lesions. J Obstet Gynaecol Res 40:1740–1747CrossRefPubMed
20.
Zurück zum Zitat Hampl M, Huppertz E, Schulz-Holstege O et al (2011) Economic burden of vulvar and vaginal intraepithelial neoplasia: retrospective cost study at a German dysplasia centre. BMC Infect Dis 11:73CrossRefPubMedPubMedCentral Hampl M, Huppertz E, Schulz-Holstege O et al (2011) Economic burden of vulvar and vaginal intraepithelial neoplasia: retrospective cost study at a German dysplasia centre. BMC Infect Dis 11:73CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Joura EA, Leodolter S, Hernandez-Avila M et al (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369:1693–1702CrossRefPubMed Joura EA, Leodolter S, Hernandez-Avila M et al (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369:1693–1702CrossRefPubMed
Metadaten
Titel
Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia
verfasst von
Matthias Jentschke
Victoria Hoffmeister
Philipp Soergel
Peter Hillemanns
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2016
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-015-3835-6

Weitere Artikel der Ausgabe 2/2016

Archives of Gynecology and Obstetrics 2/2016 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.